139 related articles for article (PubMed ID: 26113081)
21. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
22. The future: surgical advances in MEN1 therapeutic approaches and management strategies.
Sadowski SM; Cadiot G; Dansin E; Goudet P; Triponez F
Endocr Relat Cancer; 2017 Oct; 24(10):T243-T260. PubMed ID: 28811298
[TBL] [Abstract][Full Text] [Related]
23. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
Schaefer S; Shipotko M; Meyer S; Ivan D; Klose KJ; Waldmann J; Langer P; Kann PH
Eur J Endocrinol; 2008 May; 158(5):699-704. PubMed ID: 18426829
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
Dʼsouza SL; Elmunzer BJ; Scheiman JM
J Clin Gastroenterol; 2014; 48(5):458-61. PubMed ID: 24356459
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.
Conemans EB; Brosens LAA; Raicu-Ionita GM; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Timmers HTM; Offerhaus GJ; Valk GD; Vriens MR
Pancreatology; 2017; 17(5):766-772. PubMed ID: 28811081
[TBL] [Abstract][Full Text] [Related]
27. Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.
van Beek DJ; Verkooijen HM; Nell S; Bonsing BA; van Eijck CH; van Goor H; Hoogwater FJH; Nieveen van Dijkum EJM; Kazemier G; Dejong CHC; Brosens LAA; Wessels FJ; Borel Rinkes IHM; Valk GD; Vriens MR
Neuroendocrinology; 2021; 111(8):705-717. PubMed ID: 32721974
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
30. [Pulmonary neuroendocrine cell hyperplasia and tumorlets in bronchiectasis: a clinicopathologic study of 22 cases with review of literature].
Huo Z; Shi XH; Cui QC; Luo YF; Cao JL; Liu HR
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):525-9. PubMed ID: 23157743
[TBL] [Abstract][Full Text] [Related]
31. Carcinoid tumors of the lung. An analysis of 65 operated cases.
Stefani A; Morandi U; Urgese AL; Rivasi F; Lodi R
J Cardiovasc Surg (Torino); 1999 Aug; 40(4):607-12. PubMed ID: 10532229
[TBL] [Abstract][Full Text] [Related]
32. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
33. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
[TBL] [Abstract][Full Text] [Related]
34. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
Goudet P; Murat A; Cardot-Bauters C; Emy P; Baudin E; du Boullay Choplin H; Chapuis Y; Kraimps JL; Sadoul JL; Tabarin A; Vergès B; Carnaille B; Niccoli-Sire P; Costa A; Calender A;
World J Surg; 2009 Jun; 33(6):1197-207. PubMed ID: 19294466
[TBL] [Abstract][Full Text] [Related]
35. Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity.
van den Broek MFM; Levy S; Buikhuisen WA; Dijke K; Hartemink KJ; van Leeuwaarde RS; Vriens MR; Tesselaar MET; Valk GD;
J Thorac Oncol; 2021 Nov; 16(11):1810-1820. PubMed ID: 34352379
[TBL] [Abstract][Full Text] [Related]
36. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
Gatta-Cherifi B; Chabre O; Murat A; Niccoli P; Cardot-Bauters C; Rohmer V; Young J; Delemer B; Du Boullay H; Verger MF; Kuhn JM; Sadoul JL; Ruszniewski P; Beckers A; Monsaingeon M; Baudin E; Goudet P; Tabarin A
Eur J Endocrinol; 2012 Feb; 166(2):269-79. PubMed ID: 22084155
[TBL] [Abstract][Full Text] [Related]
37. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
38. Multiple endocrine neoplasia type 1 and adrenal lesions.
Barzon L; Pasquali C; Grigoletto C; Pedrazzoli S; Boscaro M; Fallo F
J Urol; 2001 Jul; 166(1):24-7. PubMed ID: 11435815
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas.
Perren A; Anlauf M; Henopp T; Rudolph T; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
J Clin Endocrinol Metab; 2007 Mar; 92(3):1118-28. PubMed ID: 17179192
[TBL] [Abstract][Full Text] [Related]
40. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
